Study Results from Sanofi in the Area of COVID-19 Reported (A Fluorospot B Assay for the Detection of Iga and Igg Sars-cov-2 Spike-specific Memory B Cells: Optimization and Qualification for Use In Covid-19 Vaccine Trials)

MLA

“Study Results from Sanofi in the Area of COVID-19 Reported (A Fluorospot B Assay for the Detection of Iga and Igg Sars-Cov-2 Spike-Specific Memory B Cells: Optimization and Qualification for Use In Covid-19 Vaccine Trials).” Vaccine Weekly, 24 May 2023, p. 616. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.750042307&authtype=sso&custid=ns315887.

APA

Study Results from Sanofi in the Area of COVID-19 Reported (A Fluorospot B Assay for the Detection of Iga and Igg Sars-cov-2 Spike-specific Memory B Cells: Optimization and Qualification for Use In Covid-19 Vaccine Trials). (2023, May 24). Vaccine Weekly, 616.

Chicago

Vaccine Weekly. 2023. “Study Results from Sanofi in the Area of COVID-19 Reported (A Fluorospot B Assay for the Detection of Iga and Igg Sars-Cov-2 Spike-Specific Memory B Cells: Optimization and Qualification for Use In Covid-19 Vaccine Trials),” May 24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.750042307&authtype=sso&custid=ns315887.